Notice NOT-MH-17-015 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-048 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-049 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-047 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-046 from the NIH Guide for Grants and Contracts

Notice NOT-GM-17-004 from the NIH Guide for Grants and Contracts

Notice NOT-AI-17-019 from the NIH Guide for Grants and Contracts

Notice NOT-CA-17-042 from the NIH Guide for Grants and Contracts

Notice NOT-HD-17-007 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-17-224 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) hereby notifies Program Director(s)/Principal Investigator(s) holding eligible awards (as specified in this FOA) that funds are available for administrative supplements to prepare and deposit individual-level data from cancer epidemiology studies into NCI-supported, controlled-access databases including the Cancer Epidemiology Data Repository (CEDR) and the database of Genotypes and Phenotypes (dbGaP). Sharing of research data will accelerate scientific discovery and increase opportunities for collaboration to provide new clues to cancer etiology, determine risk factors, and improve cancer survivorship.

Funding Opportunity PA-17-223 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for supplemental funding to eligible NCI awards so that involved personnel (awardees) can advance their efforts to gain needed knowledge on rare cancers. The goal is to support population-based, hypothesis-testing studies that will increase our understanding of the etiology or post-diagnosis outcomes of rare cancers.

Funding Opportunity PAR-17-221 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Biomedical Imaging and Bioengineering (NIBIB) R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce.

Funding Opportunity RFA-FD-17-007 from the NIH Guide for Grants and Contracts. The intended outcome of this FOA is to advance efforts for a nationally integrated food safety system by assisting retail food regulatory programs in achieving conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS or Retail Program Standards). The Retail Program Standards apply to the operation and management of a retail food regulatory program that is focused on the reduction of risk factors known to cause or contribute to foodborne illness and to the promotion of active managerial control of these risk factors. These cooperative agreements are intended to assist regulatory food retail programs in developing, implementing, and improving the infrastructure necessary to support conformance with the VNRFRPS.

Funding Opportunity PA-17-222 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) announces an opportunity for awardees holding eligible NCI-funded awards to request administrative supplement funding to support augmented efforts to refine automated methodologies to obtain more accurate and reliable lifetime residential history data and linkages that would enhance cancer research.

Notice NOT-CA-17-041 from the NIH Guide for Grants and Contracts

Notice NOT-OD-17-045 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HL-18-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites clinical research applications to investigate HIV-associated sleep disorders in adults or children using a variety of resources (e.g., existing cohorts, sample repositories) and methodologies (cellular/molecular/genomic approaches and/or vertebrate animal models). The purpose of this FOA is to elucidate mechanisms and mediators of sleep and circadian disturbances in people living with HIV, and the consequences and influences of these disturbances on other HIV-related heart, lung and blood comorbidities. Studies should address hypotheses mechanistically connecting sleep-associated disorders in the context of HIV with molecular/cellular pathways that may be related to prevalent HIV-related cardiopulmonary and/or hematological comorbidities. This FOA requires interdisciplinary collaborations among scientists across a range of relevant disciplines including circadian biology, sleep, and HIV.

Funding Opportunity PA-17-219 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. Alcohol consumption is classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC; 2010, 2012) and the National Toxicology Program (NTP; 2014) of the US Department of Health and Human Services. Target sites for alcohol-related carcinogenesis include the upper aerodigestive tract, breast, liver, and colon. A better understanding of the molecular basis by which alcohol increases cancer risk for certain tissues and organs could lead to improved therapeutic approaches and preventative strategies and would provide guidance on safe levels of alcohol consumption.

Funding Opportunity PA-17-220 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. Alcohol consumption is classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC; 2010, 2012) and the National Toxicology Program (NTP; 2014) of the US Department of Health and Human Services. Target sites for alcohol-related carcinogenesis include the upper aerodigestive tract, breast, liver, and colon. A better understanding of the molecular basis by which alcohol increases cancer risk for certain tissues and organs could lead to improved therapeutic approaches and preventative strategies and would provide guidance on safe levels of alcohol consumption.

Notice NOT-HD-17-006 from the NIH Guide for Grants and Contracts